<DOC>
	<DOCNO>NCT01140438</DOCNO>
	<brief_summary>The purpose study clarify whether patient classified Latent autoimmune diabetes adult ( LADA ) benefit early treatment insulin add per oral treatment lifestyle measure .</brief_summary>
	<brief_title>Treatment Latent Autoimmune Diabetes Adult</brief_title>
	<detailed_description>Latent autoimmune diabetes adult ( LADA ) usually define form diabetes onset diabetes take place approximately 30 year age , presence beta-cell direct antibody ( mostly anti-GAD ) clinical need insulin treatment first 6 month diagnosis diabetes . The aetiology treatment LADA patient much less elucidated case type 1 diabetes ( DM1 ) type 2 diabetes ( DM2 ) . LADA constitute 10 % total diabetic population many country . LADA therefore common insulin-requiring DM1 . LADA patient lose beta-cell function faster patient DM2 . Residual beta-cell function DM1 couple good metabolic control lesser degree hyperglycemia , less frequency hypoglycaemic event lesser diabetic complication . To retain beta-cell function LADA patient thus highly desirable . There several strategy retain beta cell function . One therapeutic strategy induce degree `` beta cell rest '' treatment exogenous insulin . Several observation indicate strategy beneficial effect . This Scandinavian multicenter non-blinded clinical trial 78 participant newly diagnose LADA . Participants randomize either insulin- per oral antidiabetic treatment . Participants follow 2 year inclusion . Beta cell function glycemic control monitor .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Repaglinide</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<criteria>Diabetes diagnose 03 year enter study . Age &gt; equal 30 year &lt; equal 75 year antiGAD positivity fast Cpeptide &gt; equal 0,3 ng/ml need insulin treatment clinical judgement least 3 month follow diagnosis diabetes . HbA1c &gt; 15 % upper limit normal Renal insufficiency ( plasma creatinine &gt; 150 mol/L ) Severe retinopathy ( proliferative preproliferative ) Severe cardiac disease ( NYHA IIIIV ) Chronic severe illness judge investigator Females reproductive age wish become pregnant study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Latent autoimmune diabetes</keyword>
	<keyword>adult</keyword>
	<keyword>Beta cell rest</keyword>
	<keyword>Insulin secretion</keyword>
</DOC>